Neumann Capital Management, LLC Gilead Sciences, Inc. Transaction History

Neumann Capital Management, LLC

$339 Million
Q4 2025

A detailed history of Neumann Capital Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Neumann Capital Management, LLC holds 36,890 shares of GILD stock, worth $4.58 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares

36,890

Previous 36,990 0.27%

Holding current value

$4.58 Million

Previous $4.11 Million 11.5%

% of portfolio

1.35%

Previous 1.21%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 14, 2026	SELL	$110.56 - $125.2 $11,056 - $12,520	-100 Reduced 0.27%	36,890 $4.58 Million
Q3 2025 Oct 15, 2025	SELL	$108.22 - $120.47 $183,974 - $204,799	-1,700 Reduced 4.39%	36,990 $4.11 Million
Q2 2025 Jul 16, 2025	SELL	$96.91 - $113.0 $77,528 - $90,400	-800 Reduced 2.03%	38,690 $4.29 Million
Q1 2025 Apr 15, 2025	SELL	$89.14 - $117.41 $26,742 - $35,223	-300 Reduced 0.75%	39,490 $4.42 Million
Q3 2024 Nov 06, 2024	SELL	$66.59 - $83.99 $99,885 - $125,984	-1,500 Reduced 3.63%	39,790 $3.34 Million

Q2 2024 Aug 09, 2024	BUY	$63.15 - $72.88 $18,945 - $21,864	300 Added 0.73%	41,290 $2.83 Million
Q1 2024 May 08, 2024	BUY	$71.58 - $87.29 $57,264 - $69,832	800 Added 1.99%	40,990 $3 Million
Q3 2023 Nov 03, 2023	SELL	$73.94 - $80.67 $44,364 - $48,402	-600 Reduced 1.47%	40,190 $3.01 Million
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $57,767 - $65,892	-760 Reduced 1.83%	40,790 $3.14 Million
Q1 2023 May 02, 2023	SELL	$77.31 - $88.08 $65,713 - $74,868	-850 Reduced 2.0%	41,550 $3.45 Million
Q4 2022 Feb 06, 2023	SELL	$62.32 - $89.47 $24,928 - $35,788	-400 Reduced 0.93%	42,400 $3.64 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $2,381 - $2,720	40 Added 0.09%	42,800 $2.64 Million
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $23,168 - $29,032	-400 Reduced 0.93%	42,760 $2.54 Million
Q3 2020 Nov 02, 2020	SELL	$62.1 - $78.08 $12,420 - $15,616	-200 Reduced 0.46%	43,160 $2.73 Million
Q2 2020 Jul 23, 2020	SELL	$72.34 - $84.0 $43,404 - $50,400	-600 Reduced 1.36%	43,360 $3.34 Million
Q4 2019 Jan 24, 2020	SELL	$61.62 - $67.78 $86,268 - $94,892	-1,400 Reduced 3.09%	43,960 $2.86 Million
Q2 2019 Jul 25, 2019	SELL	$61.87 - $69.38 $61,870 - $69,380	-1,000 Reduced 2.16%	45,360 $3.07 Million
Q1 2019 May 09, 2019	SELL	$62.53 - $70.05 $69,908 - $78,315	-1,118 Reduced 2.35%	46,360 $3.01 Million
Q4 2018 Jan 30, 2019	SELL	$60.54 - $79.0 $186,584 - $243,478	-3,082 Reduced 6.1%	47,478 $2.97 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $30,493 - $35,569	-470 Reduced 0.92%	50,560 $3.58 Million
Q1 2018 May 09, 2018	BUY	$72.84 - $88.8 $18,938 - $23,088	260 Added 0.51%	51,030 $3.85 Million
Q4 2017 Feb 05, 2018	SELL	$71.15 - $83.52 $476,989 - $559,918	-6,704 Reduced 11.66%	50,770 $3.64 Million
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $489,266 - $579,913	-6,785 Reduced 10.56%	57,474 $4.66 Million
Q2 2017 Aug 07, 2017	BUY	N/A	64,259	64,259 $4.55 Million

Others Institutions Holding GILD

# of Institutions

2,408

Shares Held

1.01B

Call Options Held

8.51M

Put Options Held

7.32M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $156B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neumann Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neumann Capital Management, LLC with notifications on news.

Account

Neumann Capital Management, LLC Gilead Sciences, Inc. Transaction History